Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
AskGene Pharma, Inc.
Scientific Title
A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ASKG315 as a Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors